Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases

Diseases of the pulmonary alveolus, such as pulmonary fibrosis, are leading causes of morbidity and mortality, but exceedingly few drugs are developed for them. A major reason for this gap is that after inhalation, drugs are quickly whisked away from alveoli due to their high perfusion. To solve thi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Laura T. Ferguson, Xiaonan Ma, Jacob W. Myerson, Jichuan Wu, Patrick M. Glassman, Marco E. Zamora, Elizabeth D. Hood, Michael Zaleski, Mengwen Shen, Eno-Obong Essien, Vladimir V. Shuvaev, Jacob S. Brenner
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley-VCH 2023-03-01
Col·lecció:	Advanced NanoBiomed Research
Matèries:	inhaled nanomedicine nintedanib; pulmonary fibrosis surfactant
Accés en línia:	https://doi.org/10.1002/anbr.202200106
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!